These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20308374)

  • 1. Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
    Jacobs MR; Good CE; Windau AR; Bajaksouzian S; Biek D; Critchley IA; Sader HS; Jones RN
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2716-9. PubMed ID: 20308374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased ceftriaxone susceptibility in emerging (35B and 6C) and persisting (19A) Streptococcus pneumoniae serotypes in the United States, 2011-2012: ceftaroline remains active in vitro among β-lactam agents.
    Mendes RE; Biek D; Critchley IA; Farrell DJ; Sader HS; Jones RN
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4923-7. PubMed ID: 24867974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
    McGee L; Biek D; Ge Y; Klugman M; du Plessis M; Smith AM; Beall B; Whitney CG; Klugman KP
    Antimicrob Agents Chemother; 2009 Feb; 53(2):552-6. PubMed ID: 19015339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftaroline Activity Against Multidrug-Resistant Streptococcus pneumoniae from U.S. Medical Centers (2014) and Molecular Characterization of a Single Ceftaroline Nonsusceptible Isolate.
    Pfaller MA; Mendes RE; Flamm RK; Jones RN; Sader HS
    Microb Drug Resist; 2017 Jul; 23(5):571-579. PubMed ID: 27918694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
    Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the activity of ceftaroline against clinical isolates of penicillin-intermediate and penicillin-resistant Streptococcus pneumoniae with elevated MICs of ceftaroline using an in vitro pharmacodynamic model.
    Zhanel GG; Yachison C; Nichol K; Adam H; Noreddin AM; Hoban DJ; Karlowsky JA
    J Antimicrob Chemother; 2012 Jul; 67(7):1706-11. PubMed ID: 22467630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.
    Critchley IA; Jacobs MR; Brown SD; Traczewski MM; Tillotson GS; Janjic N
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2639-43. PubMed ID: 18443117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AWARE Ceftaroline Surveillance Program (2008-2010): trends in resistance patterns among Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States.
    Pfaller MA; Farrell DJ; Sader HS; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S187-93. PubMed ID: 22903951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of recently collected Spanish pneumococci nonsusceptible to oral penicillin from serotypes not included in the 7-valent conjugate vaccine.
    Fenoll A; Aguilar L; Giménez MJ; Vicioso MD; Robledo O; Granizo JJ; Coronel P
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2696-8. PubMed ID: 20308373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of selected cephalosporins and erythromycin against staphylococci and pneumococci isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998.
    Jones RN; Jenkins SG; Hoban DJ; Pfaller MA; Ramphal R
    Diagn Microbiol Infect Dis; 2000 Jun; 37(2):93-8. PubMed ID: 10863103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibiotic resistance and serotype distribution of Streptococcus pneumoniae strains isolated from patients at Hacettepe University Medical Faculty].
    Yenişehirli G; Sener B
    Mikrobiyol Bul; 2003 Jan; 37(1):1-11. PubMed ID: 12838672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on antimicrobial susceptibility trends among Streptococcus pneumoniae in the United States: report of ceftaroline activity from the SENTRY Antimicrobial Surveillance Program (1998-2011).
    Jones RN; Sader HS; Mendes RE; Flamm RK
    Diagn Microbiol Infect Dis; 2013 Jan; 75(1):107-9. PubMed ID: 23009730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
    Fenoll A; Aguilar L; Robledo O; Giménez MJ; Granizo JJ; Biek D; Tarragó D
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4209-10. PubMed ID: 18725443
    [No Abstract]   [Full Text] [Related]  

  • 14. Trends in the antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006-2010.
    Tsai HY; Chen YH; Liao CH; Lu PL; Huang CH; Lu CT; Chuang YC; Tsao SM; Chen YS; Liu YC; Chen WY; Jang TN; Lin HC; Chen CM; Shi ZY; Pan SC; Yang JL; Kung HC; Liu CE; Cheng YJ; Liu JW; Sun W; Wang LS; Ko WC; Yu KW; Chiang PC; Lee MH; Lee CM; Hsu GJ; Hsueh PR
    Int J Antimicrob Agents; 2013 Oct; 42(4):312-6. PubMed ID: 23849332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of oral cephalosporins against pediatric isolates of Streptococcus pneumoniae non-susceptible to penicillin, amoxicillin or erythromycin.
    Fenoll A; Giménez MJ; Robledo O; Aguilar L; Tarragó D; Granizo JJ; Gimeno M; Coronel P
    J Chemother; 2008 Apr; 20(2):175-9. PubMed ID: 18467242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
    Seral C; Suárez L; Rubio-Calvo C; Gómez-Lus R; Gimeno M; Coronel P; Durán E; Becerril R; Oca M; Castillo FJ
    Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.
    Richter SS; Heilmann KP; Dohrn CL; Riahi F; Beekmann SE; Doern GV
    Clin Infect Dis; 2009 Feb; 48(3):e23-33. PubMed ID: 19115971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic susceptibility patterns and serotypes of antibiotic resistant and/or invasive Streptococcus pneumoniae strains circulating in Italy.
    Marchese A; Tonoli E; Balistreri G; Debbia E; Schito GC
    Microb Drug Resist; 2000; 6(2):163-70. PubMed ID: 10990272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of new cephalosporins vs Streptococcus pneumoniae from the Canadian Bacterial Surveillance Network: 2008-2011.
    Green K; McGeer A; Rudnick W; Pong-Porter S; Patel SN; Low DE;
    Curr Microbiol; 2014 Nov; 69(5):763-7. PubMed ID: 25023636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of ceftaroline against serotyped Streptococcus pneumoniae isolates from Europe and South Africa associated with community-acquired bacterial pneumonia (2007-08).
    Morrissey I; Leakey A
    J Antimicrob Chemother; 2012 Jun; 67(6):1408-12. PubMed ID: 22357801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.